Geode Capital Management
ONC

Geode Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Geode Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.87M Buy
27,617
+512
+2% +$151K ﹤0.01% 2672
2026
Q1 		$8.05M Buy
27,105
+853
+3% +$276K ﹤0.01% 2495
2025
Q4 		$7.98M Sell
26,252
-2,897
-10% -$948K ﹤0.01% 2520
2025
Q3 		$9.93M Sell
29,149
-6,467
-18% -$1.96M ﹤0.01% 2420
2025
Q2 		$8.62M Sell
35,616
-1,385
-4% -$340K ﹤0.01% 2453
2025
Q1 		$10.1M Sell
37,001
-1,251
-3% -$292K ﹤0.01% 2292
2024
Q4 		$7.07M Buy
38,252
+488
+1% +$99.7K ﹤0.01% 2562
2024
Q3 		$8.48M Sell
37,764
-50
-0.1% -$9K ﹤0.01% 2472
2024
Q2 		$5.39M Buy
37,814
+1,739
+5% +$268K ﹤0.01% 2683
2024
Q1 		$5.64M Buy
36,075
+350
+1% +$56.4K ﹤0.01% 2633
2023
Q4 		$6.44M Sell
35,725
-90
-0.3% -$16.3K ﹤0.01% 2574
2023
Q3 		$6.44M Buy
35,815
+202
+0.6% +$40K ﹤0.01% 2509
2023
Q2 		$6.35M Sell
35,613
-9,295
-21% -$2.14M ﹤0.01% 2565
2023
Q1 		$9.68M Sell
44,908
-201,460
-82% -$48.3M ﹤0.01% 2273
2022
Q4 		$54.2M Sell
246,368
-6,918
-3% -$1.27M 0.01% 1093
2022
Q3 		$34.1M Buy
253,286
+16,759
+7% +$2.88M 0.01% 1364
2022
Q2 		$38.1M Buy
236,527
+3,252
+1% +$508K 0.01% 1305
2022
Q1 		$43.7M Buy
233,275
+8,252
+4% +$1.75M 0.01% 1345
2021
Q4 		$60.6M Buy
225,023
+18,307
+9% +$6.18M 0.01% 1162
2021
Q3 		$74.5M Buy
206,716
+9,899
+5% +$3.24M 0.01% 980
2021
Q2 		$67.1M Buy
196,817
+12,171
+7% +$4.03M 0.01% 1061
2021
Q1 		$63.8M Buy
184,646
+9,227
+5% +$3.06M 0.01% 1036
2020
Q4 		$45M Sell
175,419
-33,384
-16% -$9.19M 0.01% 1171
2020
Q3 		$58.7M Buy
208,803
+12,230
+6% +$2.87M 0.01% 831
2020
Q2 		$36.5M Buy
196,573
+5,033
+3% +$819K 0.01% 1077
2020
Q1 		$23.3M Buy
191,540
+18,168
+10% +$2.84M 0.01% 1201
2019
Q4 		$28.3M Buy
173,372
+6,902
+4% +$1.15M 0.01% 1332
2019
Q3 		$20.2M Buy
166,470
+7,890
+5% +$1.05M ﹤0.01% 1485
2019
Q2 		$19.5M Buy
158,580
+19,700
+14% +$2.5M ﹤0.01% 1501
2019
Q1 		$18.1M Buy
138,880
+4,823
+4% +$651K ﹤0.01% 1476
2018
Q4 		$18.6M Buy
134,057
+108,218
+419% +$14.4M 0.01% 1330
2018
Q3 		$4.45M Buy
25,839
+998
+4% +$168K ﹤0.01% 2422
2018
Q2 		$3.82M Buy
24,841
+7,206
+41% +$1.29M ﹤0.01% 2489
2018
Q1 		$2.96M Buy
17,635
+245
+1% +$33.2K ﹤0.01% 2544
2017
Q4 		$1.7M Buy
17,390
+2,706
+18% +$248K ﹤0.01% 2848
2017
Q3 		$1.52M Buy
14,684
+973
+7% +$72.5K ﹤0.01% 2903
2017
Q2 		$616K Buy
13,711
+4,283
+45% +$169K ﹤0.01% 3282
2017
Q1 		$345K Buy
+9,428
New +$344K ﹤0.01% 3461

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management's ONC Position: Q2 2026 in Review

Geode Capital Management increased its BeOne Medicines Ltd (ONC) stake by 1.9% in Q2 2026, buying an estimated $151K and bringing the position to 27,617 shares worth $7.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2672.

Geode Capital Management first reported a position in ONC in Q1 2017 and has held it in 38 quarters since. The position peaked at $74.5M in Q3 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Geode Capital Management held 27,617 shares of BeOne Medicines Ltd worth $7.87M as of Q2 2026.
  • Geode Capital Management bought 512 BeOne Medicines Ltd shares in Q2 2026, an estimated $151K.
  • BeOne Medicines Ltd made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2672 holding.
  • Geode Capital Management first reported a position in BeOne Medicines Ltd in Q1 2017 and has held it in 38 quarters since.
  • Geode Capital Management's BeOne Medicines Ltd position peaked at $74.5M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.